Search

University of Leicester is seeking a PhD student to test the host range and properties of existing mycobacterial phages and isolate new phages against M. tuberculosis and non-tuberculous mycobacteria (NTMs, such as Mycobacterium abscessus)

We are urgently seeking Mycobacterium abscessus phages for patient in Singapore. Ways to help at this stage: - By sending your phages for testing on the patient's strains - By receiving one or more of the patient's strains and testing yo

We are urgently seeking Haemophilus influenzae phages for patient in Switzerland Ways to help at this stage: - By sending your phages for testing on the patient's strains - By receiving one or more of the patient's strains and testing you

We are urgently seeking Haemophilus influenzae phages for patient in Switzerland Ways to help at this stage: - By sending your phages for testing on the patient's strains - By receiving one or more of the patient's strains and testing you

We are urgently seeking Mycobacterium abscessus phages for patient in Singapore. Ways to help at this stage: - By sending your phages for testing on the patient's strains - By receiving one or more of the patient's strains and testing yo

In this episode of Breakpoints podcast, Dr. Saima Aslam and Dr. Daria Van Tyne join Dr. Rachel Britt for a discussion on phage therapy! Tune in for a review of their role in therapy, logistical considerations, the future of phage therapy, a

A European public consultation on a new general chapter in the European Pharmacopeia on phage therapy active substances and medicinal products of human and veterinary use is open (until end of June). This is a unique opportunity to help sha

IPATH's Translational Research in Bacteriophage Therapies Seminar Series has returned this year, featuring three speakers: Daria Van Tyne, Joseph Bondy-Denomy, and Austen Terwilliger. Watch recordings of them on YouTube, and catch upcoming

In this episode of Phage Therapy Today podcast, Dr. Gina Suh shares her recent progress and experience in applying phage therapy at Mayo Clinic.

When the CDC reported a recent outbreak of extensively drug-resistant (XDR) Pseudomonas aeruginosa linked to artificial tears, IPATH's Co-Director, Chip Schooley, requested the Pseudomonas isolates associated with the outbreak. Fortunately,

Tram Le and colleagues show the therapeutic potential of IV phage for recurrent urinary tract infections, describing a kidney transplant recipient with ESBL Klebsiella pneumoniae who was successfully treated with 4 weeks of IV phage therapy

Phages seem to be saving lives left and right, but still, they remain unapproved drugs in most countries. Pharma companies don't sell them; hospitals and pharmacies don’t stock them. In this Wired article, Maryn McKenna covers phage therapy

This review by Fazal Mehmood Khan (Shenzhen University) and colleagues provides an update on the use of animal models in phage therapy, summarizing preclinical approaches in various in-vivo models and highlighting the need for pharmacokinet

The Lee Kong Chian School of Medicine (Singapore) is seeking a Research Assistant to work with Dr. Kevin Pethe on evaluating therapeutic phages in animal models of bacterial infections.

The Department of Microbiology, Tumor and Cell Biology at Karolinska Institutet is seeking a Principal Researcher to focus on phage therapy and microbiota in women’s health.

The recording of the recent Clubhouse audio conversation on GMP phage therapy production (’Just say no to GMP?’) has just been posted! This was a talk hosted last week by Sabrina Green, Adriana Hernandez, Jean-Paul Pirnay, Patrick Druggan,

The UK parliament recently heard evidence on phages for AMR. According to Stephanie Lesage via LinkedIn: “There was a general consensus on the need to embrace the biological and unique nature of phages and find more suitable approaches to s

The Scottish Health Technologies Group has published advice on the use of phage therapy for the Scottish National Health Service. It recommends that phage therapy may be appropriate for patients with difficult to treat bacterial infections

Boston-based global health startup PhagePro has obtained an exclusive license to develop and market their phage cocktail product to prevent community spread of cholera.

A new Transplant Infectious Diseases study by Ghady Haidar (University of Pittsburgh School of Medicine) and colleagues reports the use of nebulized phage therapy to treat Burkholderia multivorans in a CF patient. Unfortunately this was a c